TY  - BOOK
AU  - Waksman, Ron
TI  - A new generation of drug-eluting stents: Indications and outcomes of bioresorbable vascular scaffolds. [Review]
SN  - 0891-1150
PY  - 2017///
KW  - *Absorbable Implants
KW  - *Coronary Artery Disease/su [Surgery]
KW  - *Coronary Restenosis/pc [Prevention & Control]
KW  - *Drug-Eluting Stents
KW  - *Percutaneous Coronary Intervention
KW  - *Tissue Scaffolds
KW  - Coronary Restenosis/et [Etiology]
KW  - Drug-Eluting Stents/ae [Adverse Effects]
KW  - Drug-Eluting Stents/cl [Classification]
KW  - Humans
KW  - Percutaneous Coronary Intervention/ae [Adverse Effects]
KW  - Percutaneous Coronary Intervention/is [Instrumentation]
KW  - Percutaneous Coronary Intervention/mt [Methods]
KW  - Treatment Outcome
KW  - MedStar Heart & Vascular Instituteon
KW  - Journal Article
KW  - Review
N1  - Available online through MWHC library: 2001- 2010, Available in print through MWHC library: 2002 - present
N2  - Drug-eluting stents (DES) are increasingly being used as a less invasive alternative to coronary artery bypass grafting. Early generation DES had durable polymers that provided acceptable efficacy outcomes but had high rates of stent thrombosis leading to myocardial infarction and death. Second-generation DES have improved outcomes by reducing stent thrombosis and recurrent stenosis. Newer DES with biodegradable polymers have similar efficacy as second-generation DES, but have higher rates of stent thrombosis. This review compares outcomes of bioresorbable scaffolds and looks at stent technology developments that may improve outcomes. Copyright (c) 2017 Cleveland Clinic
UR  - https://dx.doi.org/10.3949/ccjm.84.s4.05
ER  -